{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37867693", "DateRevised": {"Year": "2023", "Month": "10", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1021/acsomega.3c05928"], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "8", "Issue": "41", "PubDate": {"Year": "2023", "Month": "Oct", "Day": "17"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Design, Synthesis, Pharmacological Activities, Structure-Activity Relationship, and In Silico Studies of Novel 5-Substituted-2-(morpholinoimino)-thiazolidin-4-ones.", "Pagination": {"StartPage": "38641", "EndPage": "38657", "MedlinePgn": "38641-38657"}, "Abstract": {"AbstractText": ["This study is aimed to synthesize morpholine- and thiazolidine-based novel 5-(substituted)benzylidene)-2-(morpholinoimino)-3-phenylthiazolidin-4-ones (<b>3</b>-<b>26</b>) and characterized by molecular spectroscopy. The synthesized compounds were subjected to antioxidant activity with anticholinesterase, tyrosinase, and urease inhibition activities and evaluated the structure-activity relationship (SAR) of enzyme inhibition activities. Compound <b>11</b> was found to be the most active antioxidant. In anticholinesterase inhibition, compound <b>12</b> (IC<sub>50</sub>: 17.41 \u00b1 0.22 \u03bcM) was the most active against AChE, while compounds <b>3</b>-<b>26</b> ( except <b>3</b>, <b>8</b>, and <b>17</b>) showed notable activity against BChE. Compounds <b>17</b> (IC<sub>50</sub>: 3.22 \u00b1 0.70 mM), <b>15</b> (IC<sub>50</sub>: 5.19 \u00b1 0.03 mM), <b>24</b> (IC<sub>50</sub>: 7.21 \u00b1 0.27 mM), <b>23</b> (IC<sub>50</sub>: 8.05 \u00b1 0.11 mM), <b>14</b> (IC<sub>50</sub>: 8.10 \u00b1 0.22 mM), <b>25</b> (IC<sub>50</sub>: 8.40 \u00b1 0.64 mM), <b>26</b> (IC<sub>50</sub>: 8.76 \u00b1 0.90 mM), and <b>22</b> (IC<sub>50</sub>: 9.13 \u00b1 0.55 mM) produced higher tyrosinase inhibition activity. In urease inhibition activity, compounds <b>20</b> (IC<sub>50</sub>: 16.79 \u00b1 0.19 \u03bcM), <b>19</b> (IC<sub>50</sub>: 18.25 \u00b1 0.50 \u03bcM), <b>18</b> (IC<sub>50</sub>: 20.24 \u00b1 0.77 \u03bcM), <b>26</b> (IC<sub>50</sub>: 21.51 \u00b1 0.44 \u03bcM), <b>25</b> (IC<sub>50</sub>: 21.70 \u00b1 0.06 \u03bcM), and <b>24</b> (IC<sub>50</sub>: 22.49 \u00b1 0.11 \u03bcM) demonstrated excellent activities. Besides, the molecular docking study was applied to better understand the inhibitory mechanism between (<b>1-26</b>) compounds and enzymes at the molecular level. According to the results of this study, the synthesized compounds exhibited a better binding affinity toward these enzymes compared to the positive control. Further, molecular mechanics Poisson-Boltzmann surface area (MM/PBSA) binding free energy and molecular dynamics (MD) simulation analyses were performed for AChE with compound <b>26</b>, which showed high inhibitory activity in silico and in vitro studies. In conclusion, novel morpholine and thiazolidine-based derivative compounds may be pharmacologically effective agents for AChE, BChE, tyrosinase, and urease enzymes."], "CopyrightInformation": "\u00a9 2023 The Authors. Published by American Chemical Society."}, "AuthorList": [{"Identifier": ["0000-0003-2339-5837"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Aromatic Plants, K\u00f6yce\u011fiz Vocational School, Mu\u011fla S\u0131tk\u0131 Ko\u00e7man University, K\u00f6yce\u011fiz, Mu\u011fla 48800, Turkey."}], "LastName": "S\u0131cak", "ForeName": "Yusuf", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Hair Care and Beauty Services, Ye\u015filyurt Vocational School, Malatya Turgut \u00d6zal University, Malatya 44210, Turkey."}], "LastName": "Aktar", "ForeName": "Bedriye Seda Kur\u015fun", "Initials": "BSK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biostatistics and Medical Informatics, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080, Turkey."}], "LastName": "Y\u0131lmaz", "ForeName": "Gizem Tatar", "Initials": "GT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Aromatic Plants, K\u00f6yce\u011fiz Vocational School, Mu\u011fla S\u0131tk\u0131 Ko\u00e7man University, K\u00f6yce\u011fiz, Mu\u011fla 48800, Turkey."}], "LastName": "\u00d6zt\u00fcrk", "ForeName": "Fatma Aydo\u011fmu\u015f", "Initials": "FA"}, {"Identifier": ["0000-0001-8932-4535"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Sciences, Mu\u011fla S\u0131tk\u0131 Ko\u00e7man University, Mu\u011fla 48121, Turkey."}], "LastName": "\u00d6zt\u00fcrk", "ForeName": "Mehmet", "Initials": "M"}, {"Identifier": ["0000-0002-0064-8400"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Arts and Sciences, Gaziantep University, Gaziantep 27310, Turkey."}], "LastName": "Tok", "ForeName": "Tu\u011fba Ta\u015fk\u0131n", "Initials": "TT"}, {"Identifier": ["0000-0001-6840-9660"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Arts and Sciences, Gaziantep University, Gaziantep 27310, Turkey."}], "LastName": "Emre", "ForeName": "Emine El\u00e7in Oru\u00e7", "Initials": "EEO"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Burns J.; Gardner P. T.; Matthews D.; Duthie G. G.; Lean J.; Crozier A. Extraction of phenolics and changes in antioxidant activity of red wines during vilification. J. Agric. Food Chem. 2001, 49, 5797\u20135808. 10.1021/jf010682p.", "ArticleIdList": ["10.1021/jf010682p", "11743766"]}, {"Citation": "Khan I.; Ali S.; Hameed S.; Rama N. H.; Hussain M. T.; Wadood A.; Uddin R.; Ul-Haq Z.; Khan A.; Ali S.; Choudhary M. I. Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5200\u20135207. 10.1016/j.ejmech.2010.08.034.", "ArticleIdList": ["10.1016/j.ejmech.2010.08.034", "20828889"]}, {"Citation": "Cadenas E.; Davies K. J. A. Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Bio. Med. 2000, 29, 222\u2013230. 10.1016/S0891-5849(00)00317-8.", "ArticleIdList": ["10.1016/S0891-5849(00)00317-8", "11035250"]}, {"Citation": "Nijveldt R. J.; van Nood E.; van Hoorn D. E.; Boelens P. G.; van Norren K.; van Leeuwen P. A. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 2001, 74, 418\u2013425. 10.1093/ajcn/74.4.418.", "ArticleIdList": ["10.1093/ajcn/74.4.418", "11566638"]}, {"Citation": "Neha K.; Haider M. R.; Pathak A.; Yar M. S. Medicinal prospects of antioxidants: A review. Eur. J. Med. Chem. 2019, 178, 687\u2013704. 10.1016/j.ejmech.2019.06.010.", "ArticleIdList": ["10.1016/j.ejmech.2019.06.010", "31228811"]}, {"Citation": "Suleman M.; Khan A.; Baqi A.; Kakar M. S.; Samiullah Ayub M. Antioxidants, its role in preventing free radicals and infectious diseases in human body. Pure Appl. Biol. 2019, 8, 380\u2013388. 10.19045/bspab.2018.700197.", "ArticleIdList": ["10.19045/bspab.2018.700197"]}, {"Citation": "Ito N.; Fukushima S.; Hagiwara A.; Shibata M.; Ogiso T. Carcinogenicity of butylated hydroxyanisole in F344 rats. J. Natl. Cancer Inst. 1983, 70, 343\u2013347. 10.1093/jnci/70.2.343.", "ArticleIdList": ["10.1093/jnci/70.2.343", "6571941"]}, {"Citation": "Yildirim A.; Oktay M.; Bilaloglu V. The antioxidant activity of the leaves of Cydonia vulgaris. Turk. J. Med. Sci. 2001, 31, 23\u201327."}, {"Citation": "Beard C. M.; Kokmen E.; Sigler C.; Smith G. E.; Petterson T.; O\u2019Brien P. C. Cause of death in Alzheimer\u2019s disease. Ann. Epidemiol. 1996, 6, 195\u2013200. 10.1016/1047-2797(95)00068-2.", "ArticleIdList": ["10.1016/1047-2797(95)00068-2", "8827154"]}, {"Citation": "Sadashiva C. T.; Narendra Sharath Chandra J. N.; Ponnappa K. C.; Veerabasappa Gowda T.; Rangappa K. S. Synthesis and efficacy of 1-bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholineesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer\u2019s disease. Bioorg. Med. Chem. Lett. 2006, 16, 3932\u20133936. 10.1016/j.bmcl.2006.05.030.", "ArticleIdList": ["10.1016/j.bmcl.2006.05.030", "16735118"]}, {"Citation": "Alzheimer\u2019s Disease International . 2019. World Alzheimer Report 2019: Attitudes to dementia; Alzheimer\u2019s Disease International, London."}, {"Citation": "Terry A. V.; Buccafusco J. J. The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 2003, 306, 821\u2013827. 10.1124/jpet.102.041616.", "ArticleIdList": ["10.1124/jpet.102.041616", "12805474"]}, {"Citation": "Selkoe D. J. Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81, 741\u2013766. 10.1152/physrev.2001.81.2.741.", "ArticleIdList": ["10.1152/physrev.2001.81.2.741", "11274343"]}, {"Citation": "Giacobini E. Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol. Res. 2004, 5, 433\u2013440. 10.1016/j.phrs.2003.11.017.", "ArticleIdList": ["10.1016/j.phrs.2003.11.017", "15304240"]}, {"Citation": "Asadipour A.; Alipour M.; Jafari M.; Khoobi M.; Emami S.; Nadri H.; Sakhteman A.; Moradi A.; Sheibani V.; Homayouni Moghadam F.; Shafiee A.; Foroumadi A. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Eur. J. Med. Chem. 2013, 70, 623\u2013630. 10.1016/j.ejmech.2013.10.024.", "ArticleIdList": ["10.1016/j.ejmech.2013.10.024", "24211638"]}, {"Citation": "Habtemariam S. Natural products in Alzheimer\u2019s disease therapy: would old therapeutic approaches fix the broken promise of modern medicines?. Molecules 2019, 24, 1519.10.3390/molecules24081519.", "ArticleIdList": ["10.3390/molecules24081519", "PMC6514598", "30999702"]}, {"Citation": "David D. A.; Casey A.; O\u2019Brien J. Drugs for Alzheimer\u2019s disease: are they effective?. Pharm. Therapeut. 2010, 35, 208\u2013211.", "ArticleIdList": ["PMC2873716", "20498822"]}, {"Citation": "Damghani T.; Hadaegh S.; Khoshneviszadeh M.; Pirhadi S.; Sabet R.; Khoshneviszadeh M.; Edraki N. Design, synthesis, in vitro evaluation and molecular docking study of N\u2019-Arylideneimidazo[1,2-a]pyridine-2-carbohydrazide derivatives as novel tyrosinase inhibitors. J. Mol. Struct. 2020, 1222, 12887610.1016/j.molstruc.2020.128876.", "ArticleIdList": ["10.1016/j.molstruc.2020.128876"]}, {"Citation": "Kawakami A.; Fisher D. E. Key discoveries in melanocyte development. J. Invest. Dermatol. 2011, 131, E2\u2013E4. 10.1038/skinbio.2011.2.", "ArticleIdList": ["10.1038/skinbio.2011.2", "22094402"]}, {"Citation": "Mason H. S. The chemistry of melanin: III. mechanism of the oxidation of dihydroxyphenylalanine by tyrosinase. J. Biol. Chem. 1948, 172, 83\u201399. 10.1016/S0021-9258(18)35614-X.", "ArticleIdList": ["10.1016/S0021-9258(18)35614-X", "18920770"]}, {"Citation": "Nouveau S.; Agrawal D.; Kohli M.; Bernerd F.; Misra N.; Nayak C. Skin hyperpigmentation in Indian population: insights and best practice. Indian J. Dermatol. 2016, 61, 487\u2013495. 10.4103/0019-5154.190103.", "ArticleIdList": ["10.4103/0019-5154.190103", "PMC5029232", "27688436"]}, {"Citation": "Dogra S.; Sarangal R. Pigmentary disorders: an insight. Pigment Int. 2014, 1, 5\u20137. 10.4103/2349-5847.135429.", "ArticleIdList": ["10.4103/2349-5847.135429"]}, {"Citation": "Ujan R.; Saeed A.; Ashraf S.; Channar P. A.; Abbas Q.; Rind M. A.; Hassan M.; Raza H.; Seo S. Y.; El-Seedi H. R. Synthesis, computational studies and enzyme inhibitory kinetics of benzothiazole-linked thioureas as mushroom tyrosinase inhibitors. J. Biomol. Struct. Dyn. 2020, 39, 7024\u20137043. 10.1080/07391102.2020.1804459.", "ArticleIdList": ["10.1080/07391102.2020.1804459", "32762529"]}, {"Citation": "Hasegawa T. Tyrosinase-expressing neuronal cell lines as in vitro model of Parkinson\u2019s disease. Int. J. Mol. Sci. 2010, 11, 1082\u20131089. 10.3390/ijms11031082.", "ArticleIdList": ["10.3390/ijms11031082", "PMC2869230", "20480001"]}, {"Citation": "Neagu E.; Paun G.; Albu C.; Radu G. L. Assessment of acetylcholinesterase and tyrosinase inhibitory and antioxidant activity of Alchemilla vulgaris and Filipendula ulmaria extracts. J. Taiwan Inst. Chem. Eng. 2015, 52, 1\u20136. 10.1016/j.jtice.2015.01.026.", "ArticleIdList": ["10.1016/j.jtice.2015.01.026"]}, {"Citation": "Lapedriza A.; Petratou K.; Kelsh R. N.. Chapter 14 - Neural crest cells and pigmentation, In Neural Crest Cells; Elsevier, 2014, 287\u2013311, 10.1016/B978-0-12-401730-6.00015-6.", "ArticleIdList": ["10.1016/B978-0-12-401730-6.00015-6"]}, {"Citation": "Chang T. S. An updated review of tyrosinase inhibitors. Int. J. Mol. Sci. 2009, 10, 2440\u20132475. 10.3390/ijms10062440.", "ArticleIdList": ["10.3390/ijms10062440", "PMC2705500", "19582213"]}, {"Citation": "Larik F. A.; Saeed A.; Channar P. A.; Muqadar U.; Abbas Q.; Hassan M.; Seo S. Y.; Bolte M. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers. Eur. J. Med. Chem. 2017, 141, 273\u2013281. 10.1016/j.ejmech.2017.09.059.", "ArticleIdList": ["10.1016/j.ejmech.2017.09.059", "29040952"]}, {"Citation": "Hu Y. H.; Chen Q. X.; Cui Y.; Gao H. J.; Xu L.; Yu X. Y.; Wang Y.; Yan C. L.; Wang Q. 4-Hydroxy cinnamic acid as mushroom preservation: anti-tyrosinase activity kinetics and application. Int. J. Biol. Macromol. 2016, 86, 489\u2013495. 10.1016/j.ijbiomac.2016.01.070.", "ArticleIdList": ["10.1016/j.ijbiomac.2016.01.070", "26812105"]}, {"Citation": "Collins C. M.; D\u2019Orazio S. E. F. Bacterial ureases: structure, regulation of expression and role in pathogenesis. Mol. Microbiol. 1993, 9, 907\u2013913. 10.1111/j.1365-2958.1993.tb01220.x.", "ArticleIdList": ["10.1111/j.1365-2958.1993.tb01220.x", "7934918"]}, {"Citation": "Ghous T.; Akhtar K.; Choudhry M. A. Screening of selected medicinal plants for urease inhibitory activity. Biol. Med. 2010, 2, 64\u201369."}, {"Citation": "Houimel M.; Mach J. P.; Corth\u00e9sy-Theulaz I.; Corthesy B.; Fisch I. New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries. Eur. J. Biochem. 1999, 262, 774\u2013780. 10.1046/j.1432-1327.1999.00430.x.", "ArticleIdList": ["10.1046/j.1432-1327.1999.00430.x", "10411639"]}, {"Citation": "Mobley H. L.; Hausinger R. P. Microbial ureases: signicance, regulation, and molecular characterization. Microbiol. Rev. 1989, 53, 85\u2013108. 10.1128/mr.53.1.85-108.1989.", "ArticleIdList": ["10.1128/mr.53.1.85-108.1989", "PMC372718", "2651866"]}, {"Citation": "Karplus P. A.; Pearson M. A.; Hausinger R. P. 70 Years of Crystalline Urease: What Have We Learned?. Acc. Chem. Res. 1997, 30, 330\u2013337. 10.1021/ar960022j.", "ArticleIdList": ["10.1021/ar960022j"]}, {"Citation": "Mobley H. L.; Island M. D.; Hausinger R. P. Molecular biology of microbial ureases. Microbiol. Rev. 1995, 59, 451\u2013480. 10.1128/mr.59.3.451-480.1995.", "ArticleIdList": ["10.1128/mr.59.3.451-480.1995", "PMC239369", "7565414"]}, {"Citation": "Li X.; Mobley H. L. T. Vaccines for Proteus mirabilish in urinary tract infection. Int. J. Antimicrob. 2002, 19, 461\u2013465. 10.1016/S0924-8579(02)00102-4.", "ArticleIdList": ["10.1016/S0924-8579(02)00102-4", "12135833"]}, {"Citation": "Hausinger R. P.; Karplus P. A. In Handbook of Metalloproteins; Messerschmidt A.; Hubber R.; Poulos T.; Wieghardt K., eds.; John Wiley & Sons: Chichester, UK, 2001, 867\u2013879."}, {"Citation": "Kisby B.; Jarrell J. T.; Agar M. E.; Cohen D. S.; Rosin E. R.; Cahill C. M.; Rogers J. T.; Huang X. Alzheimer\u2019s disease and its potential alternative therapeutics. J. Alzheimers Dis. Parkinsonism. 2019, 9, 477.10.4172/2161-0460.1000477.", "ArticleIdList": ["10.4172/2161-0460.1000477", "PMC6777730", "31588368"]}, {"Citation": "Re R.; Pellegrini N.; Proteggente A.; Pannala A.; Yang M.; Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol. Med. 1999, 26, 1231\u20131237. 10.1016/S0891-5849(98)00315-3.", "ArticleIdList": ["10.1016/S0891-5849(98)00315-3", "10381194"]}, {"Citation": "Miller H. E. A simplified method for the evaluation of antioxidants. J. Am. Oil Chem. Soc. 1971, 45, 91.10.1007/BF02635693.", "ArticleIdList": ["10.1007/BF02635693"]}, {"Citation": "Blois M. S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181, 1199\u20131200. 10.1038/1811199a0.", "ArticleIdList": ["10.1038/1811199a0"]}, {"Citation": "Apak R.; G\u00fc\u00e7l\u00fc K.; \u00d6zy\u00fcrek M.; Karademir S. E. Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method. J. Agric. Food Chem. 2004, 52, 7970\u20137981. 10.1021/jf048741x.", "ArticleIdList": ["10.1021/jf048741x", "15612784"]}, {"Citation": "Ellman G. L.; Courtney K. D.; Andres V.; Featherstone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7, 88\u201395. 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}, {"Citation": "Hearing V. J.Methods in Enzymology; Academic Press: New York, 1987, 142, 154\u2013165.", "ArticleIdList": ["3110555"]}, {"Citation": "Khatib S.; Nerya O.; Musa R.; Shumel M.; Tamir S.; Vaya J. Chalcones as potent tyrosinase inhibitors: The importance of 2,4-disubstituted resorcinol moiety. Bioorg. Med. Chem. 2005, 13, 433\u2013441. 10.1016/j.bmc.2004.10.010.", "ArticleIdList": ["10.1016/j.bmc.2004.10.010", "15598564"]}, {"Citation": "Weatherburn M. W. Phenol-hypochlorite reaction for determination of ammonia. Anal. Chem. 1967, 39, 971\u2013974. 10.1021/ac60252a045.", "ArticleIdList": ["10.1021/ac60252a045"]}, {"Citation": "Jurrus E.; Engel D.; Star K.; Monson K.; Brandi J.; Felberg L. E.; Brookes D. H.; Wilson L.; Chen J.; Liles K.; Chun M.; Li P.; Gohara D. W.; Dolinsky T.; Konecny R.; Koes D. R.; Nielsen J. E.; Head-Gordon T.; Geng W.; Krasny R.; Wei G.; Holst M. J.; McCammon J. A.; Baker N. A. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 2018, 27, 112\u2013128. 10.1002/pro.3280.", "ArticleIdList": ["10.1002/pro.3280", "PMC5734301", "28836357"]}, {"Citation": "Foresman J. B.; Frish E.. Exploring Chemistry with Electronic Structure Methods; Gaussian Inc.1996, USA."}, {"Citation": "Ravindranath P. A.; Forli S.; Goodsell D. S.; Olson A. J.; Sanner M. F. AutoDockFR: Advances in protein-ligand docking with explicitly specified binding site flexibility. PLOS Comput. Biol. 2015, 11, e100458610.1371/journal.pcbi.1004586.", "ArticleIdList": ["10.1371/journal.pcbi.1004586", "PMC4667975", "26629955"]}, {"Citation": "Morris G. M.; Huey R.; Lindstrom W.; Sanner M. F.; Belew R. K.; Goodsell D. S.; Olson A. J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30, 2785\u20132791. 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Vanommeslaeghe K.; Hatcher E.; Acharya C.; Kundu S.; Zhong S.; Shim J.; Darian E.; Guvench O.; Lopes P.; Vorobyov I.; Mackerell A. D. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 2010, 31, 671\u2013690. 10.1002/jcc.21367.", "ArticleIdList": ["10.1002/jcc.21367", "PMC2888302", "19575467"]}, {"Citation": "Huang J.; Mackerell A. D. CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. J. Comput. Chem. 2013, 34, 2135\u20132145. 10.1002/jcc.23354.", "ArticleIdList": ["10.1002/jcc.23354", "PMC3800559", "23832629"]}, {"Citation": "Homeyer N.; Gohlke H. Free energy calculations by the molecular mechanics poisson-Boltzmann surface area method. Mol. Inform. 2012, 31, 114\u2013122. 10.1002/minf.201100135.", "ArticleIdList": ["10.1002/minf.201100135", "27476956"]}, {"Citation": "Kumari R.; Kumar R.; Lynn A. g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 2014, 54, 1951\u20131962. 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "Ravez S.; Corbet C.; Spillier Q.; Feron O.; Frederick R.. Serine biosynthetic pathway inhibitors, 2017, WO 2017157882A1."}, {"Citation": "Dong G.; Liu Y.; Wu Y.; Tu J.; Chen S.; Liu N.; Sheng C. Novel non-peptic small molecule inhibitors of secreted aspartic protease 2 (SAP2) for the treatment of resistant fungal infections. Chem. Commun. 2018, 54, 13535\u201313538. 10.1039/C8CC07810F.", "ArticleIdList": ["10.1039/C8CC07810F", "30431632"]}, {"Citation": "Bruno G.; Costantino L.; Curinga C.; Maccari R.; Monforte F.; Nicolo F.; Ottana R.; Vigorita M. G. Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. Bioorg. Med. Chem. 2002, 10, 1077\u20131084. 10.1016/S0968-0896(01)00366-2.", "ArticleIdList": ["10.1016/S0968-0896(01)00366-2", "11836118"]}, {"Citation": "Dawood K. M.; Eldebss T. M. A.; El-Zahabi H. S. A.; Yousef M. H.; Metz P. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents. Eur. J. Med. Chem. 2013, 70, 740\u2013749. 10.1016/j.ejmech.2013.10.042.", "ArticleIdList": ["10.1016/j.ejmech.2013.10.042", "24231309"]}, {"Citation": "Madhava G.; Subbaiah V.; Sreenivasulu R.; Raju C. N. Synthesis of novel urea and thiourea derivatives of diphenylphosphoramidate and their antimicrobial activity. Pharm. Lett. 2012, 4, 1194\u20131201."}, {"Citation": "Ramla M. M.; Omar M. A.; Tokudab H.; El-Diwani H. I. Synthesis and inhibitory activity of new benzimidazole derivatives against Burkitt\u2019s lymphoma promotion. Bioorg. Med. Chem. 2007, 15, 6489\u20136496. 10.1016/j.bmc.2007.04.010.", "ArticleIdList": ["10.1016/j.bmc.2007.04.010", "17643992"]}, {"Citation": "Bhandari S. V.; Bothara K. G.; Patil A. A.; Chitre T. S.; Sarkate A. P.; Gore S. T.; Dangre S. C.; Khachane C. V. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach. Bioorg. Med. Chem. 2009, 17, 390\u2013400. 10.1016/j.bmc.2008.10.032.", "ArticleIdList": ["10.1016/j.bmc.2008.10.032", "19036593"]}, {"Citation": "Bhalgat C. M.; Darda P. V.; Bothara K. G.; Bhandari S. V.; Gandhi J.; Ramesh B. Synthesis and pharmacological screening of some novel anti-hypertensive agents possessing 5-benzylidene-2-(phenylimino)-thiazolidin-4-one ring. Eur. J. Med. Chem. 2014, 76, 580\u2013588. 10.1016/j.ejmech.2014.02.048.", "ArticleIdList": ["10.1016/j.ejmech.2014.02.048", "24637077"]}, {"Citation": "Patil S. G.; Bagul R. R.; Swami M. S.; Hallale S. N.; Kamble V. M.; Kotharkar N. S.; Darade K. Synthesis of 2-imino 4-thiazolidino derivatives and its antibacterial activity. J. Chem. Pharm. Res. 2011, 3, 69\u201376."}, {"Citation": "Faidallah H. M.; Khan K. A.; Asiri A. M. Synthesis and biological evalution of new 3,5-di(trifluoromethyl)-1,2,4-triazolesulfonylurea and thiourea derivatives as antidiabetic and antimicrobial agents. J. Fluor. Chem. 2013, 132, 870\u2013877. 10.1016/j.jfluchem.2011.06.014.", "ArticleIdList": ["10.1016/j.jfluchem.2011.06.014"]}, {"Citation": "Barak D.; Kronman C.; Ordentlich A.; Ariel N.; Bromberg A.; Marcus D.; Lazar A.; Velan B.; Shafferman A. Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharinga common core. J. Biol. Chem. 1994, 269, 6296\u20136305.", "ArticleIdList": ["8119978"]}, {"Citation": "Quinn D. M. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem. Rev. 1987, 87, 955\u2013979. 10.1021/cr00081a005.", "ArticleIdList": ["10.1021/cr00081a005"]}, {"Citation": "Zou C.; Huang W.; Zhao G.; Wan X.; Hu X.; Jin Y.; Li J.; Liu J. Determination of the bridging ligand in the active site of tyrosinase. Molecules 2017, 22, 1836.10.3390/molecules22111836.", "ArticleIdList": ["10.3390/molecules22111836", "PMC6150207", "29143758"]}, {"Citation": "Juszkiewicz A.; Zaborska W.; Sepio\u0142 J.; G\u00f3ra M.; Zaborska A. Inactivation of Jack Bean Urease by Allicin. J. Enzyme Inhib. Med. Chem. 2013, 18, 419\u2013424. 10.1080/1475636031000152286.", "ArticleIdList": ["10.1080/1475636031000152286", "14692509"]}, {"Citation": "Kr\u00e1tk\u00fd M.; \u0160t\u011bp\u00e1nkov\u00e1 \u0160.; Vor\u010d\u00e1kov\u00e1 K.; \u0160varcov\u00e1 M.; Vin\u0161ov\u00e1 J. Novel cholinesterase inhibitors based on O-aromatic N,N-disubstituted carbamates and thiocarbamates. Molecules 2016, 21, 191.10.3390/molecules21020191.", "ArticleIdList": ["10.3390/molecules21020191", "PMC6274279", "26875979"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "11"}, {"Year": "2023", "Month": "9", "Day": "20"}, {"Year": "2023", "Month": "10", "Day": "23", "Hour": "6", "Minute": "50"}, {"Year": "2023", "Month": "10", "Day": "23", "Hour": "6", "Minute": "49"}, {"Year": "2023", "Month": "10", "Day": "23", "Hour": "4", "Minute": "28"}, {"Year": "2023", "Month": "10", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["37867693", "PMC10586451", "10.1021/acsomega.3c05928"]}}], "PubmedBookArticle": []}